Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis
Takayuki Ise(Tokushima University Hospital), Masafumi Kitakaze(Hanwa Memorial Hospital), Akira Funada(National Cerebral and Cardiovascular Center), Shiro Kamakura(The Japanese Society of Gastroenterological Surgery), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Toshihisa Anzai(Hokkaido University), Takuya Hasegawa(Tokyo Institute of Technology), Makoto Amaki(National Cerebral and Cardiovascular Center), Hideo Okamura(Kobe University), Yoshiaki Morita(Osaka City University), Hiroyuki Takahama(Tohoku University), Naoaki Yamada(National Cerebral and Cardiovascular Center), Wataru Shimizu(Nippon Medical School Hospital)
Cited by 165
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
|European Heart Journal|2018|2.1k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Magnetic properties of Mn-doped ZnO
|Applied Physics Letters|2001|663